{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-9/paragraph-1",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-9/paragraph-1.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/9/paragraph/1",
  "kind": "paragraph",
  "number": "1",
  "heading": "The continuity principles",
  "text": "(1) Where by virtue of this Schedule—\n(a) a matter is to be dealt with in accordance with the 2006 Regulations or the 2012 Regulations; or\n(b) a matter (by virtue of having been dealt with in accordance with Schedule 7 to the 2012 Regulations (transitional provisions)), is to be dealt with in accordance with the 2005 Regulations or the SCAT Regulations,\nif that matter under those Regulations would fall to be dealt with by a Primary Care Trust, unless the context requires otherwise, that matter is to be dealt with instead by NHS England.\n(2) Any matter that is ongoing under the 2006 Regulations or the 2012 Regulations (including, by virtue of Schedule 7 of those Regulations, under the 2005 Regulations or the SCAT Regulations) immediately before the appointed day, unless the context requires otherwise—\n(a) is to be treated as ongoing under these Regulations on the appointed day (and where appropriate after that); and\n(b) where that matter becomes the responsibility of NHS England on the appointed day, anything done in relation to that matter by or with regard to a Primary Care Trust before the appointed day is to be treated as having been done (for the purposes of the ongoing treatment of the matter) by or with regard to NHS England.\n(3) Where a period of time specified in a provision of the 2006 Regulations or the 2012 Regulations is current on the appointed day, and a period of time is also specified in a corresponding provision of these Regulations, unless the context requires otherwise, these Regulations have effect as if the corresponding provision of these Regulations had been in force when that period began to run.\n(4) Where—\n(a) consideration of a matter under a provision of these Regulations in respect of a specified period of time requires consideration of a period of time before the appointed day; and\n(b) a corresponding provision of the 2006 Regulations or the 2012 Regulations also required consideration of that matter in respect of a specified period of time,\nunless the context requires otherwise, the provision of these Regulations has effect as if it had been in force when the period of time specified in it began to run.\n(5) Subject to sub-paragraphs (6) and (7), where on or after the appointed day—\n(a) a matter is to be dealt with in accordance with the SCAT Regulations, the 2005 Regulations, the 2006 Regulations or the 2012 Regulations; or\n(b) a matter that relates to circumstances that arose, or first arose, before the appointed day is to be dealt with in accordance with these Regulations or the Drug Tariff,\nin dealing with that matter NHS England (or where appropriate, on appeal, the Secretary of State or the First-tier Tribunal) is to apply those Regulations, the Drug Tariff and related provisions of the 2006 Act subject to such modifications as it (or where appropriate, on appeal, the Secretary of State or the First-tier Tribunal) considers necessary or expedient.\n(6) Modifications pursuant to paragraph (5) must—\n(a) be for a purpose related to—\n(i) dealing with the matter justly, or\n(ii) effecting an orderly transition from the scheme established by the Regulations mentioned in sub-paragraph (5)(a), read with the 2006 Act as in force before the appointed day, to the scheme established by these Regulations, read with the 2006 Act,\nor for purposes related to both; and\n(b) take account, as appropriate, of the manner in which—\n(i) provisions in the 2005 Regulations were carried forward into the 2012 Regulations,\n(ii) provisions in the 2006 Regulations and the 2012 Regulations were carried forward into these Regulations, and\n(iii) the 2006 Act was amended by the Health and Social Care Act 2012 .\n(7) Modifications pursuant to paragraph (5) may—\n(a) be for the purpose of seeking to ensure that a matter is dealt with expeditiously;\n(b) be for the purpose of seeking to ensure that a matter is dealt with proportionately, having regard to (as relevant)—\n(i) the importance of protecting the safety of persons to whom pharmaceutical and local pharmaceutical services are provided,\n(ii) the need for fairness,\n(iii) the complexity of the issues,\n(iv) the importance of protecting NHS England from material financial loss, and\n(v) the importance of saving expense; or\n(c) (without prejudice to the generality of the power to make modifications) have the effect of—\n(i) adding to, modifying or removing functions that would have been performed by a Primary Care Trust under the SCAT Regulations, the 2005 Regulations, the 2006 Regulations, the 2012 Regulations or the 2006 Act as in force before the appointed day, or\n(ii) adding to, modifying or removing functions that are to be performed by NHS England or a HWB under these Regulations or the 2006 Act.\n(8) In this Schedule, “the continuity principles” means the provisions of sub-paragraphs (1) to (7).",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "2012 c. 7."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/9/paragraph/1",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}